Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 840 | 565 | 412 | 541 | 279 |
| Cost of Goods | 200 | 382 | 224 | 410 | 195 |
| Gross Profit | 639 | 184 | 187 | 132 | 84 |
| Operating Expenses | 1,361 | 1,420 | 1,491 | 1,721 | 1,090 |
| Operating Income | -722 | -1,236 | -1,303 | -1,590 | -1,007 |
| Interest Expense | 156 | 141 | 133 | 127 | 74 |
| Other Income | 83 | 225 | 179 | 133 | 82 |
| Pre-tax Income | -795 | -1,152 | -1,257 | -1,583 | -999 |
| Net Income Continuous | -795 | -1,152 | -1,257 | -1,583 | -999 |
| Minority Interests | -105 | 44 | -12 | 60 | 94 |
| Net Income | $-900 | $-1,109 | $-1,269 | $-1,523 | $-904 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-565 | $-952 | $-1,063 | $-1,398 | $-878 |